News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
683,372 Results
Type
Article (57568)
Company Profile (85)
Press Release (625625)
Multimedia
Podcasts (244)
Webinars (21)
Section
Business (209919)
Career Advice (2871)
Deals (33702)
Drug Delivery (174)
Drug Development (78499)
Employer Resources (179)
FDA (16390)
Job Trends (14977)
News (318411)
Policy (31982)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2945)
Academic (1)
Accelerated approval (59)
ADA (49)
Adcomms (42)
Allergies (199)
Alliances (46090)
ALS (240)
Alzheimer's disease (1996)
Antibody-drug conjugate (ADC) (564)
Approvals (16794)
Artificial intelligence (825)
ASCO (335)
Autoimmune disease (371)
Automation (67)
Bankruptcy (337)
Best Places to Work (11649)
BIO (67)
BIOSECURE Act (23)
Biosimilars (249)
Biotechnology (66)
Bladder cancer (212)
Brain cancer (81)
Breast cancer (842)
Cancer (6624)
Cardiovascular disease (572)
Career advice (2449)
Career pathing (53)
CAR-T (377)
CDC (76)
Celiac Disease (3)
Cell therapy (1027)
Cervical cancer (60)
Clinical research (68732)
Collaboration (2332)
Commercialization (1)
Company closure (7)
Compensation (1549)
Complete response letters (112)
COVID-19 (3001)
CRISPR (119)
C-suite (1382)
Cystic fibrosis (165)
Data (8848)
Decentralized trials (3)
Denatured (91)
Depression (199)
Dermatology (106)
Diabetes (695)
Diagnostics (7461)
Digital health (65)
Diversity (14)
Diversity, equity & inclusion (45)
Drug discovery (409)
Drug pricing (232)
Drug shortages (39)
Duchenne muscular dystrophy (326)
Earnings (68966)
Editorial (80)
Employer branding (23)
Employer resources (164)
Events (93216)
Executive appointments (1242)
FDA (20529)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1927)
Gene editing (269)
Generative AI (76)
Gene therapy (826)
GLP-1 (1250)
Government (5140)
Grass and pollen (6)
Guidances (423)
Healthcare (19242)
Hematology (194)
HIV (102)
Huntington's disease (71)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (120)
Immunology and inflammation (344)
Immuno-oncology (119)
Indications (224)
Infectious disease (3392)
Inflammatory bowel disease (238)
Inflation Reduction Act (17)
Influenza (150)
Intellectual property (334)
Interviews (534)
IPO (16052)
IRA (59)
Job creations (3595)
Job search strategy (2005)
JPM (73)
Kidney cancer (25)
Labor market (107)
Layoffs (666)
Leadership (55)
Legal (6998)
Liver cancer (108)
Longevity (36)
Lung cancer (889)
Lymphoma (484)
Machine learning (68)
Management (63)
Manufacturing (1247)
Marketing (7)
MASH (225)
Medical affairs (1)
Medical device (13521)
Medtech (13700)
Mergers & acquisitions (19051)
Metabolic disorders (1809)
mRNA (274)
Multiple sclerosis (211)
NASH (24)
Neurodegenerative disease (525)
Neuropsychiatric disorders (127)
Neuroscience (3758)
Neurotech (1)
NextGen: Class of 2026 (6777)
Non-profit (4766)
Now hiring (68)
Obesity (863)
Opinion (364)
Ovarian cancer (244)
Pain (290)
Pancreatic cancer (363)
Parkinson's disease (410)
Partnered (38)
Patents (670)
Patient recruitment (816)
Peanut (67)
People (63417)
Pharmaceutical (25)
Pharmacy benefit managers (35)
Phase 1 (21119)
Phase 2 (30202)
Phase 3 (23063)
Pipeline (10326)
Policy (400)
Postmarket research (2483)
Preclinical (9019)
Press Release (69)
Prostate cancer (345)
Psychedelics (78)
Radiopharmaceuticals (359)
Rare diseases (1301)
Real estate (5689)
Recruiting (77)
Regulatory (26102)
Reports (46)
Research institute (2651)
Resumes & cover letters (447)
Rett syndrome (47)
RNA editing (29)
RSV (95)
Schizophrenia (196)
Series A (326)
Series B (244)
Service/supplier (3)
Sickle cell disease (131)
Special edition (31)
Spinal muscular atrophy (184)
Sponsored (51)
Startups (3573)
State (2)
Stomach cancer (19)
Supply chain (141)
Tariffs (97)
The Weekly (150)
Vaccines (1294)
Venture capital (138)
Weight loss (589)
Women's health (141)
Worklife (25)
Date
Today (96)
Last 7 days (456)
Last 30 days (1992)
Last 365 days (30068)
2026 (17142)
2025 (29683)
2024 (34262)
2023 (38819)
2022 (49825)
2021 (54142)
2020 (53408)
2019 (47011)
2018 (35737)
2017 (32668)
2016 (31503)
2015 (36241)
2014 (27498)
2013 (22917)
2012 (24264)
2011 (24943)
2010 (22315)
Location
Africa (935)
Alabama (99)
Alaska (7)
Arizona (318)
Arkansas (15)
Asia (41269)
Australia (7235)
California (13312)
Canada (3919)
China (1607)
Colorado (578)
Connecticut (613)
Delaware (427)
Europe (95616)
Florida (2108)
Georgia (440)
Hawaii (2)
Idaho (64)
Illinois (1116)
India (103)
Indiana (638)
Iowa (24)
Japan (611)
Kansas (136)
Kentucky (46)
Louisiana (56)
Maine (69)
Maryland (1578)
Massachusetts (9496)
Michigan (352)
Minnesota (715)
Mississippi (6)
Missouri (147)
Montana (35)
Nebraska (29)
Nevada (151)
New Hampshire (85)
New Jersey (3593)
New Mexico (35)
New York (3616)
North Carolina (1734)
North Dakota (11)
Northern California (6631)
Ohio (426)
Oklahoma (22)
Oregon (40)
Pennsylvania (2617)
Puerto Rico (33)
Rhode Island (52)
South America (1255)
South Carolina (89)
South Dakota (2)
Southern California (5408)
Tennessee (229)
Texas (2229)
United States (47590)
Utah (421)
Vermont (2)
Virginia (340)
Washington D.C. (78)
Washington State (1079)
West Virginia (4)
Wisconsin (148)
Wyoming (2)
683,372 Results for "heartsciences formerly known as heart test labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
March 16, 2026
·
6 min read
Press Releases
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
March 24, 2026
·
3 min read
Press Releases
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
December 16, 2025
·
5 min read
Insights
Labs see rising demand for nitrosamine, topical performance and microbiome testing
Recent
BioSpace
industry conference conversations point to sponsors pushing earlier on safety, quality and performance data, leading to demand for nitrosamine analysis, IVRT/IVPT and microbiome database capabilities.
June 25, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Press Releases
Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
July 8, 2026
·
6 min read
Press Releases
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
February 5, 2026
·
4 min read
Business
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
Heart Test Laboratories, Inc.d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) today reported financial results for the third quarter fiscal 2024 ended January 31, 2024 and provided a business update.
March 14, 2024
·
8 min read
Lone Star Bio
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”) today announced that the Canadian Intellectual Property Office Application No. 3,000,369 has been granted by the Canadian Intellectual Property Office.
March 6, 2024
·
4 min read
Press Releases
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 25, 2025
·
6 min read
Press Releases
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule
June 30, 2026
·
5 min read
1 of 68,338
Next
